infliximab,vedolizumab,ozanimod
takeda,janssen,bms
[' cam ', 'ibd']
the roadmap of agents that can target leukocyte trafficking is no longer short! #aibd2022 
Gastroenterologist with focus on #IBD and quality improvement @utswnews (Tweets mine, not medical advice, of course)